Skip to content
  • Friday, June 6, 2025

New Economy World

The world economy is the economy of all humans in the world

Banner Add
  • Home
  • Blog
  • Finance News
  • Insurance
  • Investing
  • Construction
  • Property
  • Stock
  • Tech
  • Venture Capital
  • Home
  • Stock
  • Lyft director John Zimmer sells $30,339 in class A stock
Stock

Lyft director John Zimmer sells $30,339 in class A stock

27/02/2025
admin


Lyft director John Zimmer sells $30,339 in class A stock#Lyft #director #John #Zimmer #sells #class #stock

Tags: Class, Director, John, Lyft, sells, stock, Zimmer

Post navigation

Meta is reportedly planning a standalone AI chatbot app
JRI: Limited NAV Growth And Shrinking Earnings

Finance and Economics

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin
Finance News

Rubrik, Inc. (RBRK) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

bernstein socgen group cuts crowdstrike stock rating to market perform

06/06/2025
admin
Finance News

Whitehaven Coal: Caught In The Political Crossfire

06/06/2025
admin
Stock

India cenbank delivers larger-than-expected 50 bps cut in key rate

06/06/2025
admin
Finance News

ChargePoint: Weak Quarter And Disappointing Outlook – Sell (Rating Downgrade)

06/06/2025
admin

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin

Recent Posts

Finance News

DocuSign, Inc. (DOCU) Q1 2026 Earnings Call Transcript

06/06/2025
admin
Stock

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

06/06/2025
admin
New Economy World News